Jill M Kolesar (Jill Kolesar, Fred Ueland)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 30

Top Topics

Radical Prostatectomy

Clinical Decision Support

Chronic Myeloid Leukemia

Top Venues

Diagnostics (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

J Robert McCorkle, Rebecca Ahn, Connie D Cao, Kristen S Hill, Charles S Dietrich, Jill M Kolesar
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer. Cancers 16 (7) (2024)
J Robert McCorkle, Rebecca Ahn, Connie D Cao, Kristen S Hill, Charles S Dietrich, Jill M Kolesar
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer. Cancers 16 (7) (2024)
J Robert McCorkle, Rebecca Ahn, Connie D Cao, Kristen S Hill, Charles S Dietrich, Jill M Kolesar
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer. Cancers 16 (7) (2024)
Taylor A Rives, Heather Pavlik, Ning Li, Lien Qasrawi, Donglin Yan, Justine Pickarski, Charles S Dietrich, Rachel W Miller, Frederick R Ueland, Jill M Kolesar
Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice. Cancers 15 (12) (2023)
Namrata Anand, Keng Hee Peh, Jill M Kolesar
Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma. International journal of molecular sciences 24 (3) (2023)
Laura M Harbin, Nan Lin, Frederick R Ueland, Jill M Kolesar
SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer. International journal of molecular sciences 24 (18) (2023)
Taylor A Rives, Heather Pavlik, Ning Li, Lien Qasrawi, Donglin Yan, Justine Pickarski, Charles S Dietrich, Rachel W Miller, Frederick R Ueland, Jill M Kolesar
Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice. Cancers 15 (12) (2023)
Namrata Anand, Keng Hee Peh, Jill M Kolesar
Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma. International journal of molecular sciences 24 (3) (2023)
Zin W Myint, William H St Clair, Stephen E Strup, Donglin Yan, Ning Li, Derek B Allison, Laurie E McLouth, Carleton S Ellis, Peng Wang, Andrew C James, Patrick J Hensley, Danielle E Otto, Susanne M Arnold, Robert S DiPaola, Jill M Kolesar
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer. Cancers 15 (9) (2023)
Zin W Myint, William H St Clair, Stephen E Strup, Donglin Yan, Ning Li, Derek B Allison, Laurie E McLouth, Carleton S Ellis, Peng Wang, Andrew C James, Patrick J Hensley, Danielle E Otto, Susanne M Arnold, Robert S DiPaola, Jill M Kolesar
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer. Cancers 15 (9) (2023)
Nathan D Seligson, Jill M Kolesar, Benish Alam, Laura Baker, Jatinder Kaur Lamba, Brooke L Fridley, Ameen A Salahudeen, Daniel Louis Hertz, J Kevin Hicks
Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer. Pharmacogenomics (2023)
Namrata Anand, Keng Hee Peh, Jill M Kolesar
Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma. International journal of molecular sciences 24 (3) (2023)
Hannah G McDonald, Megan M Harper, Kristen S Hill, Anqi Gao, Angelica L Solomon, Charles J Bailey, Miranda Lin, Mautin Barry-Hundeyin, Michael J Cavnar, Samuel H Mardini, Prakash J Pandalai, Reema A Patel, Jill M Kolesar, Justin A Rueckert, Lawrence Hookey, Mark Ropeleski, Shaila J Merchant, Joseph Kim, Mei Gao
Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment Responses. Cancers 15 (11) (2023)
Spencer R Rosario, Bowen Dong, Yali Zhang, Hua-Hsin Hsiao, Emily Isenhart, Jianmin Wang, Erin M Siegel, Arta M Monjazeb, Dwight H Owen, Prasenjit Dey, Fred K Tabung, Daniel J Spakowicz, William J Murphy, Stephen Edge, Sai Yendamuri, Sami Ibrahimi, Jill M Kolesar, Patsy H McDonald, Deepak Vadehra, Michelle Churchman, Song Liu, Pawel Kalinski, Sarbajit Mukherjee
Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers. International journal of molecular sciences 24 (13) (2023)
David Schweer, Annabel McAtee, Khaga Neupane, Christopher Richards, Frederick Rand Ueland, Jill M Kolesar
Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy. Cancers 14 (9) (2022)
Suhas Shivajirao Bhosale, Abhisek Mandal, Caixia Hou, J Robert McCorkle, David Schweer, Kristen S Hill, Vivekanandan Subramanian, Jill M Kolesar, Oleg V Tsodikov, Jürgen Rohr
Mithplatins: Mithramycin SA-Pt(II) Complex Conjugates for the Treatment of Platinum-Resistant Ovarian Cancers. ChemMedChem (2022)
Aman Chauhan, Alexandre Prieur, Jill M Kolesar, Susanne Arnold, Léa Payen, Younes Mahi, Berengere Vire, Madison Sands, B Mark Evers, Dominique Joubert, Lowell B Anthony
hPG 80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors. Cancers 14 (4) (2022)
Megan Leigh Hutchcraft, Shulin Zhang, Nan Lin, Ginny Lee Gottschalk, James W Keck, Elizabeth A Belcher, Catherine Sears, Chi Wang, Kun Liu, Lauren E Dietz, Justine C Pickarski, Sainan Wei, Roberto Cardarelli, Robert S DiPaola, Jill M Kolesar
Real-World Evaluation of a Population Germline Genetic Screening Initiative for Family Medicine Patients. Journal of personalized medicine 12 (8) (2022)
Laura M Harbin, Holly H Gallion, Derek B Allison, Jill M Kolesar
Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer-An Opportunity for Targeted Therapy. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Anthony McDowell, Kristen S Hill, J Robert McCorkle, Justin Gorski, Ameen A Salahudeen, Frederick Rand Ueland, Jill M Kolesar, Jill M Kolesar
Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment. Diagnostics (Basel, Switzerland) 11 (3) (2021)
Megan Leigh Hutchcraft, Nan Lin, Shulin Zhang, Catherine Sears, Kyle Zacholski, Elizabeth A Belcher, Eric B Durbin, John L Villano, Michael J Cavnar, Susanne M Arnold, Frederick Rand Ueland, Jill M Kolesar
Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes. Cancers 13 (18) (2021)
Megan Leigh Hutchcraft, Holly H Gallion, Jill M Kolesar
MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer. Diagnostics (Basel, Switzerland) 11 (1) (2021)
Justin W Gorski, Zhuwei Zhang, J Robert McCorkle, Jodi M DeJohn, Chi Wang, Rachel W Miller, Holly H Gallion, Charles S Dietrich, Frederick Rand Ueland, Jill M Kolesar
Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance. Biomedicines 9 (8) (2021)
David Schweer, J Robert McCorkle, Jurgen Rohr, Oleg V Tsodikov, Frederick Rand Ueland, Jill M Kolesar
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer. Biomedicines 9 (1) (2021)
Kristen S Hill, Anthony McDowell, J Robert McCorkle, Erin Schuler, Sally R Ellingson, Rina Plattner, Jill M Kolesar
KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer. Cancers 13 (8) (2021)
Jill M Kolesar, Tyler Gayheart, Lance Poston, Eric Monday, Derek Forster, Elizabeth Belcher, Rani Jaiswal, J Kirsten Turner, Donna K Arnett, Eric B Durbin, Joseph Monroe, Frank Romanelli, Susanne M Arnold, C Darrell Jennings, Heidi Weiss, Robert DiPaola
COVID-19 Test Strategy to Guide Quarantine Interval in University Student. medRxiv : the preprint server for health sciences (2020)
Anmi Jose, Gautham G Shenoy, Gabriel Sunil Rodrigues, Naveena Kumar An, Murali Munisamy, Levin Thomas, Jill M Kolesar, Ganesha Rai, Praveen P N Rao, Mahadev Rao
Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy. Cancers 12 (8) (2020)
Justin W Gorski, Frederick Rand Ueland, Jill M Kolesar
CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer. Diagnostics (Basel, Switzerland) 10 (5) (2020)
Brian T Burgess, Abigail M Anderson, J Robert McCorkle, Jianrong Wu, Frederick Rand Ueland, Jill M Kolesar
Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells. Diagnostics (Basel, Switzerland) 10 (2) (2020)
Erin M Bertino, Ryan D Gentzler, Sarah Clifford, Jill M Kolesar, Alona Muzikansky, Eric B Haura, Zofia Piotrowska, D Ross Camidge, Thomas E Stinchcombe, Christie J Lau, Jyoti Malhotra, Liza C Villaruz, Cloud P Paweletz, Lynette Sholl, Naoko Takebe, Jeffrey A Moscow, Geoffrey I Shapiro, Pasi A Jänne, Geoffrey R Oxnard
Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903). Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2020)